Biotechnology plays a crucial role in developing new and improved vaccines through several innovative approaches: These biotechnological advancements have significantly […]
Biotechnology and the Microbiome: Exploring New Horizons Read Post »
In the ever-evolving pharmaceutical landscape, the art of tablet formulation is a delicate dance between active ingredients and excipients. Excipients, often referred to as the unsung heroes of drug development, play a pivotal role in ensuring the effi…
Optimizing Tablet Formulations: The Crucial Role of Excipient Selection Read Post »
The biotechnology sector continues to be a dynamic and rapidly evolving field, with companies pushing the boundaries of science and
Top Biotechnology Companies Leading the Way in 2024 Read Post »
Annual Drug Patent Expirations for IGALMI Igalmi is a drug marketed by Bioxcel and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug. This drug has sixty-five patent family members in sixteen countr…
Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. PHEXXI drug price trends. This drug has sixty-four patent fami…
Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. PHEXXI drug price trends. This drug has sixty-four patent fami…
Annual Drug Patent Expirations for JULUCA Juluca is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. JULUCA drug price trends. Drug patent litigation for JULUCA…
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs. There are three patents protecting this compound. Drug pat…
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs. There are three patents protecting this compound. Drug pat…
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the pharmaceutical companies with the most patents in South Korea. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired. For a global perspective, see the Drug companies wi…
Which pharmaceutical companies have the most drug patents in South Korea? Read Post »
Get new actionable insights and updates from BiotechBlog
